Cochrane · systematic review · CD012382

Non‐steroidal anti‐inflammatory drugs for sciatica

Rasmussen‐Barr, E, Held, U, Grooten, WJA, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

Back and NeckAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 50%Low 2 · 50%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

NSAIDs compared with placebo for low back pain with sciatica

Population: people with low back pain with sciatica
4 questions
OutcomeEffectEvidenceStatus / GRADE
Change in pain intensity from baseline on VAS (0 to 100) short‐term
NSAIDs vs placebo
no estimate extracted3 studies · 918 participantsVery low
Downgraded: risk of bias, inconsistency
Change in disability from baseline to
NSAIDs vs placebo
no estimate extracted1 study · 214 participantsVery low
Downgraded: risk of bias, inconsistency
Global Improvement short‐term
NSAIDs vs placebo
RR 1.143 studies · 753 participantsLow
Downgraded: risk of bias, inconsistency
Side effects short‐term
NSAIDs vs placebo
RR 1.44 studies · 967 participantsLow
Downgraded: risk of bias, inconsistency